Amy Belisle, MD, MBA
Senior Medical Director

State governments and communities across the United States are leading a range of efforts to address the epidemic of Substance Use Disorder (SUD) and Opioid Use Disorder (OUD), yet we continue to see a steady increase in the rate of opioid-related drug overdose deaths in most states. Qualidigm provides expertise, experience, and technical assistance related to clinical improvement initiatives that can be leveraged to support state and community initiatives aimed at addressing this epidemic and decreasing opioid overdose deaths. Our range of initiatives to address OUD include:

  • Leadership programs that engage clinicians and communities in a compassionate response to the opioid epidemic
  • Strategies to decrease and improve the safety of prescribing opioids and other medications including benzodiazepines
  • Treatment and access to Medication-Assisted Treatment (MAT) and Medication-Assisted Recovery (MAR)
  • Promotion of overdose prevention and harm reduction, including the use of naloxone, and utilizing ODMAP to build community support
  • Strategies to improve care for women with perinatal substance use and substance exposed infants
  • Educational platforms including in person meetings, virtual meetings/webinars, Project ECHO®, learning sessions, and technical support

Featured Work

Addressing Maine’s Opioid Epidemic

Initiating MAT Induction in EDs

See More Examples of Our Work Experience